Mirabegron Completed Phase 1 Trials for Pharmacokinetics / Cardiovascular / Healthy Volunteers

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01489696A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin
NCT01199523A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females
NCT01478503To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females